Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
This two-day program was attended by 40 doctors & paramedical staff
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
Dyslipidemia is a critical risk factor for cardiovascular diseases
Nadda expressed his concern about growing incidence of Non-Communicable Diseases and the importance of awareness regarding healthy diet and lifestyle
Sanofi will leverage this partnership to provide access to proprietary data to develop AI models
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
Subscribe To Our Newsletter & Stay Updated